Cellectis S.A.
CMVLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $41,506 | $755 | $19,171 | $73,949 |
| % Growth | 5,397.5% | -96.1% | -74.1% | – |
| Cost of Goods Sold | $0 | $737 | $1,772 | $36,275 |
| Gross Profit | $41,506 | $18 | $17,399 | $37,674 |
| % Margin | 100% | 2.4% | 90.8% | 50.9% |
| R&D Expenses | $90,536 | $87,646 | $97,501 | $86,950 |
| G&A Expenses | $17,602 | $16,812 | $17,494 | $37,869 |
| SG&A Expenses | $17,602 | $14,801 | $17,494 | $44,201 |
| Sales & Mktg Exp. | $0 | -$2,011 | $0 | $6,332 |
| Other Operating Expenses | -$7,078 | $0 | $0 | $0 |
| Operating Expenses | $101,060 | $90,002 | $107,065 | $123,111 |
| Operating Income | -$59,554 | -$108,857 | -$89,666 | -$85,437 |
| % Margin | -143.5% | -14,418.2% | -467.7% | -115.5% |
| Other Income/Exp. Net | $22,793 | -$7,610 | -$8,935 | $2,520 |
| Pre-Tax Income | -$36,761 | -$116,467 | -$98,601 | -$97,483 |
| Tax Expense | $0 | $371 | $87 | -$11,203 |
| Net Income | -$36,761 | -$103,174 | -$106,139 | -$81,074 |
| % Margin | -88.6% | -13,665.4% | -553.6% | -109.6% |
| EPS | -0.41 | -1.77 | -2.33 | -1.81 |
| % Growth | 76.8% | 24% | -28.7% | – |
| EPS Diluted | -0.41 | -1.77 | -2.33 | -1.81 |
| Weighted Avg Shares Out | 90,566 | 57,013 | 45,547 | 44,820 |
| Weighted Avg Shares Out Dil | 90,566 | 57,013 | 45,547 | 44,820 |
| Supplemental Information | – | – | – | – |
| Interest Income | $11,278 | $3,690 | $1,141 | $736 |
| Interest Expense | $7,453 | $6,563 | $16,633 | $5,338 |
| Depreciation & Amortization | $19,020 | $18,523 | $18,773 | $13,613 |
| EBITDA | -$15,159 | -$92,636 | -$76,378 | -$83,147 |
| % Margin | -36.5% | -12,269.7% | -398.4% | -112.4% |